Lubbe W F, McFadyen M L, Muller C A, Worthington M, Opie L H
Am J Cardiol. 1979 Mar;43(3):533-40. doi: 10.1016/0002-9149(79)90010-9.
The pretreatment of rats with amiodarone for 2 minutes to 3 weeks before the excision of their hearts caused a dose-related decrease in heart rate and an increase in the ventricular fibrillation threshold both before and after coronary arterial ligation. Similarly, amiodarone decreased the incidence of ventricular premature extrasystoles, ventricular tachycardia and fibrillation during the period of regional ischemia after coronary arterial ligation and also after reperfusion of the ischemic myocardium. There was no evidence of a metabolic protective effect on ischemic myocardium because tissue high energy phosphate content decreased to a similar extent in ischemic myocardium from control and amiodarone-treated rats. Instead, the protective effect of amiodarone against fibrillation was accompanied by attenuation of the increase in tissue cyclic adenosine monophosphate in ischemic myocardium after coronary arterial ligation. It is proposed that amiodarone exerts a potent antifibrillatory effect by decreasing tissue cyclic adenosine monophosphate in ischemic myocardium.
在切除大鼠心脏前2分钟至3周用胺碘酮预处理,导致心率呈剂量相关下降,且在冠状动脉结扎前后心室颤动阈值均升高。同样,胺碘酮降低了冠状动脉结扎后局部缺血期间以及缺血心肌再灌注后室性早搏、室性心动过速和颤动的发生率。没有证据表明对缺血心肌有代谢保护作用,因为对照大鼠和胺碘酮处理大鼠的缺血心肌中组织高能磷酸含量下降程度相似。相反,胺碘酮对颤动的保护作用伴随着冠状动脉结扎后缺血心肌中组织环磷酸腺苷增加的减弱。有人提出,胺碘酮通过降低缺血心肌中的组织环磷酸腺苷发挥强大的抗颤动作用。